Skip to Main Content
CKG
Home
Home
Home
TKG
Paper Details
Breadcrumb
Paper Details
Paper Title
Author Correction: Targeting wild-type KRAS-amplified gastroesophageal cancer through combined MEK and SHP2 inhibition.
PubMed
Paper Journal Title
Nat Med
Paper Citation Count
4
Paper Publication Year
2018
Bio Mention
KRAS, MEK, SHP2, actin, gastroesophageal cancer, wild
Mesh Descriptor
Go
Actions
Author Name
Affiliation
Steven E Schumacher
The Broad Institute of MIT and Harvard
Austin Dulak
Dana-Farber Cancer Institute
Austin Dulak
Christopher Szeto
John Alan Diehl
Medical University of South Carolina
Philipp Mertins
The Broad Institute of MIT and Harvard
Philipp Mertins
Max Delbruck Center for Molecular Medicine
Steven A Carr
The Broad Institute of MIT and Harvard
Steven A Carr
The Broad Institute of MIT and Harvard
Rameen Beroukhim
Dana-Farber Cancer Institute
Rameen Beroukhim
Dana-Farber Cancer Institute
Rameen Beroukhim
Brigham and Women's Hospital
Rameen Beroukhim
Harvard Medical School
Rameen Beroukhim
The Broad Institute of MIT and Harvard
Adam J Bass
Harvard Medical School
Adam J Bass
Brigham and Women's Hospital
Adam J Bass
Dana-Farber Cancer Institute
Adam J Bass
The Broad Institute of MIT and Harvard
1 - 18
Column Actions
Search
Datasets